Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

LY4064912

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 1 TRIAL

A Study of LY4064912 in Healthy Participants and With Overweight or Obesity

ClinicalTrials.gov

Phase 1 safety and tolerability study in healthy volunteers and patients with overweight/obesity; no results reported in this registry record.

PreliminaryEli Lilly and Company LY4064912 Overweight Or Obesity

Reported

Planned enrollment144

Study phasePhase 1

Primary outcome measureNumber of Participants with One or More Ser…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support